Hi All...I'm new-ish here; at least I've never posted. This article bugs me...it plays at being a 'real' medical article and could be accepted as such by folks that don't know better. Here's the link from our governments national institute of health website:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782393/If you check the Disclosures and Ethics section at the end of this "peer-reviewed" article, you'll see what I'd call a fabrication: AcknowledgementsThe authors gratefully acknowledge the staff at Narconon of Oklahoma and Narconon International for project support.Competing InterestsAuthor(s) disclose no potential conflicts of interest.Disclosures and EthicsAs a requirement of publication the authors have provided signed confirmation of their compliance with ethical and legal obligations including but not limited to compliance with ICMJE authorship and competing interests guidelines, that the article is neither under consideration for publication nor published elsewhere, of their compliance with legal and ethical guidelines concerning human and animal research participants (if applicable), and that permission has been obtained for reproduction of any copyrighted material. This article was subject to blind, independent, expert peer review. The reviewers reported no competing interests.FundingFunding for this work was provided by Narconon of Oklahoma and Narconon International.No competing interests....bull@$#!
A little bird tells me that the publication has received some mail about a potential conflict of interest.
Ill find out this week when I meet with some official officials who are very interested in this sort of thing. . Notice how I didnt name names? Hi Narconon staff lurkers!
Richard Lennox is an interesting Google search – he’s one of the owners of Chestnut Health Systems:http://www.chestnut.org/which owns Chesnut Global:http://www.chestnutglobalpartners.org/AboutUs/OurParentCompanyChestnutHealthSystemsbios are here:http://www.chestnutglobalpartners.org/DivisionofCommercialScience/DivisionofCommercialScienceStaffUnclear whether this is a pay for publication group or not – they may be a group of actual scientists that got sucked into a Narconon thing without being aware of how far the rabbit hole goes. Can anyone check him against Scientology course completion databases? If he’s not, he’d be an easy one to email and enlighten about the truth behind it all.
Chestnut Health Systems' Executive Leadership Mark W. Campbell, Director of Human Resources James G. Fraser, Director of Business Developmenthttp://www.truthaboutscientology.com/stats/by-name/m/mark-campbell.htmlhttp://www.truthaboutscientology.com/stats/by-name/j/james-fraser.html
“Low pay, decent benefits, poor management”Anonymous Employee (Former Employee)I worked at Chestnut Health Systems full-time for less than a yearPros – There are a lot of good people working at Chestnut which helps make the day go by faster.Cons – Horrible pay and my direct managers were immature, threw fits, pouted, and treated their subordinates like morons.Advice to Senior Management – Act more professional and mature. Don't treat your employees like they're stupid.No, I would not recommend this company to a friend
Subst Abuse. 2014; 8: 53.Published online Jul 3, 2014. doi: 10.4137/SART.S16517PMCID: PMC4085139Correction for “A Simplified Method for Routine Outcome Monitoring after Drug Abuse Treatment”Richard D. Lennox,1 Marie A. Sternquist,1,2 and Alfonso Paredes3Author information ► Copyright and License information ►This corrects the article "A Simplified Method for Routine Outcome Monitoring after Drug Abuse Treatment" in volume 7 on page 155.This is a correction for Lennox RD, Sternquist MA and Paredes A. A Simplified Method for Routine Outcome Monitoring after Drug Abuse Treatment. Substance Abuse: Research and Treatment. 2013:7 155–169. DOI 10.1047/SART. S12691.A potential competing non-financial interest was not disclosed by an author of this paper. Dr. Paredes is a member of Narconon International’s volunteer science advisory committee. The editor in chief acknowledges that the non-disclosure was unintentional and that the authors responded promptly and constructively when the matter was raised. This matter has been investigated in accordance with the relevant COPE procedure.
QuoteThis is a correction for Lennox RD, Sternquist MA and Paredes A. A Simplified Method for Routine Outcome Monitoring after Drug Abuse Treatment. Substance Abuse: Research and Treatment. 2013:7 155–169. DOI 10.1047/SART. S12691.A potential competing non-financial interest was not disclosed by an author of this paper. Dr. Paredes is a member of Narconon International’s volunteer science advisory committee. The editor in chief acknowledges that the non-disclosure was unintentional and that the authors responded promptly and constructively when the matter was raised. This matter has been investigated in accordance with the relevant COPE procedure.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085139/Brother......Well, better than nothing.
This is a correction for Lennox RD, Sternquist MA and Paredes A. A Simplified Method for Routine Outcome Monitoring after Drug Abuse Treatment. Substance Abuse: Research and Treatment. 2013:7 155–169. DOI 10.1047/SART. S12691.A potential competing non-financial interest was not disclosed by an author of this paper. Dr. Paredes is a member of Narconon International’s volunteer science advisory committee. The editor in chief acknowledges that the non-disclosure was unintentional and that the authors responded promptly and constructively when the matter was raised. This matter has been investigated in accordance with the relevant COPE procedure.
And what about disclosing Marie Cecchini-Sternquist's interests?
Quote from: DeathHamster on September 07, 2014, 10:24And what about disclosing Marie Cecchini-Sternquist's interests?I don't know how they overlooked that!